|
Volumn 34, Issue 7, 2002, Pages 1008-1016
|
Results of 2 years of treatment with protease-inhibitor-containing antiretroviral therapy in dutch children infected with human immunodeficiency virus type 1
a,b c a c d e b b b b d a f g g h h d d b more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
INDINAVIR;
LAMIVUDINE;
NELFINAVIR;
PROTEINASE INHIBITOR;
ZIDOVUDINE;
ABDOMINAL PAIN;
ADOLESCENT;
AREA UNDER THE CURVE;
ARTICLE;
CELL COUNT;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
FEMALE;
FLUID INTAKE;
HEADACHE;
HEMATURIA;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFANT;
MALE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
TREATMENT OUTCOME;
UNITED KINGDOM;
VIRUS DETECTION;
VIRUS LOAD;
VOMITING;
ADOLESCENT;
CD4 LYMPHOCYTE COUNT;
CHILD;
CHILD, PRESCHOOL;
DRUG THERAPY, COMBINATION;
FEMALE;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
INDINAVIR;
INFANT;
LAMIVUDINE;
MALE;
NELFINAVIR;
NETHERLANDS;
PROSPECTIVE STUDIES;
REVERSE TRANSCRIPTASE INHIBITORS;
TREATMENT OUTCOME;
ZIDOVUDINE;
|
EID: 0036531979
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/339443 Document Type: Article |
Times cited : (35)
|
References (37)
|